276 related articles for article (PubMed ID: 23131123)
1. A review of methods for detect human Papillomavirus infection.
Abreu AL; Souza RP; Gimenes F; Consolaro ME
Virol J; 2012 Nov; 9():262. PubMed ID: 23131123
[TBL] [Abstract][Full Text] [Related]
2. Overview: Detection of Human Papillomavirus in Clinical Samples.
Prakrankamanant P; Wongsena M
J Med Assoc Thai; 2016 Jan; 99 Suppl 1():S89-96. PubMed ID: 26817243
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the f-HPV typing™ and Hybrid Capture II® assays for detection of high-risk HPV genotypes in cervical samples.
Cañadas MP; Cirigliano V; Darwich L; Sirera G; Coll J; Clotet B; Videla S
J Virol Methods; 2012 Jul; 183(1):14-8. PubMed ID: 22449759
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of an array-based method for human papillomavirus detection and genotyping in comparison with conventional methods used in cervical cancer screening.
García-Sierra N; Martró E; Castellà E; Llatjós M; Tarrats A; Bascuñana E; Díaz R; Carrasco M; Sirera G; Matas L; Ausina V
J Clin Microbiol; 2009 Jul; 47(7):2165-9. PubMed ID: 19439534
[TBL] [Abstract][Full Text] [Related]
5. HPV mRNA test in women with minor cervical lesions: experience of the University Hospital of North Norway.
Sorbye SW; Fismen S; Gutteberg TJ; Mortensen ES
J Virol Methods; 2010 Oct; 169(1):219-22. PubMed ID: 20638416
[TBL] [Abstract][Full Text] [Related]
6. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.
Torres-Poveda K; Ruiz-Fraga I; Madrid-Marina V; Chavez M; Richardson V
BMC Cancer; 2019 Dec; 19(1):1205. PubMed ID: 31823749
[TBL] [Abstract][Full Text] [Related]
7. Laboratory and clinical aspects of human papillomavirus testing.
Chan PK; Picconi MA; Cheung TH; Giovannelli L; Park JS
Crit Rev Clin Lab Sci; 2012; 49(4):117-36. PubMed ID: 22913405
[TBL] [Abstract][Full Text] [Related]
8. Human Papillomavirus.
Burd EM; Dean CL
Microbiol Spectr; 2016 Aug; 4(4):. PubMed ID: 27726787
[TBL] [Abstract][Full Text] [Related]
9. Cervical biopsies and cytological smears - a comparison of sample materials in HPV diagnostics.
Webersinke C; Doppler S; Roithmeier F; Stummvoll W; Silye R
J Clin Virol; 2013 Jan; 56(1):69-71. PubMed ID: 23072707
[TBL] [Abstract][Full Text] [Related]
10. Detection of human papillomavirus DNA in urine. A review of the literature.
Vorsters A; Micalessi I; Bilcke J; Ieven M; Bogers J; Van Damme P
Eur J Clin Microbiol Infect Dis; 2012 May; 31(5):627-40. PubMed ID: 21818524
[TBL] [Abstract][Full Text] [Related]
11. High performance of combined HPV testing and genotyping for HPV16/18/52/58 in triaging women with minor cervical cytological abnormalities in northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Intaraphet S; Siriaunkgul S
J Med Virol; 2016 Jan; 88(1):135-43. PubMed ID: 26129775
[TBL] [Abstract][Full Text] [Related]
12. Type-specific detection of high-risk human papillomavirus (HPV) in self-sampled cervicovaginal cells applied to FTA elute cartridge.
Gustavsson I; Sanner K; Lindell M; Strand A; Olovsson M; Wikström I; Wilander E; Gyllensten U
J Clin Virol; 2011 Aug; 51(4):255-8. PubMed ID: 21632283
[TBL] [Abstract][Full Text] [Related]
13. A comparative review of laboratory-developed tests utilizing Invader HPV analyte-specific reagents for the detection of high-risk human papillomavirus.
Stillman MJ; Day SP; Schutzbank TE
J Clin Virol; 2009 Jul; 45 Suppl 1():S73-7. PubMed ID: 19651372
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical performance of Abbott RealTime High Risk HPV test with that of hybrid capture 2 assay in a screening setting.
Carozzi FM; Burroni E; Bisanzi S; Puliti D; Confortini M; Giorgi Rossi P; Sani C; Scalisi A; Chini F
J Clin Microbiol; 2011 Apr; 49(4):1446-51. PubMed ID: 21325553
[TBL] [Abstract][Full Text] [Related]
15. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
16. Introduction of human papillomavirus DNA screening in the world: 15 years of experience.
Castle PE; de Sanjosé S; Qiao YL; Belinson JL; Lazcano-Ponce E; Kinney W
Vaccine; 2012 Nov; 30 Suppl 5():F117-22. PubMed ID: 23199954
[TBL] [Abstract][Full Text] [Related]
17. Comparison of INNO-LiPA genotyping extra and hybrid capture 2 assays for detection of carcinogenic human papillomavirus genotypes.
Barzon L; Militello V; Pagni S; Palù G
J Clin Virol; 2012 Nov; 55(3):256-61. PubMed ID: 22877561
[TBL] [Abstract][Full Text] [Related]
18. Novel microsphere-based method for detection and typing of 46 mucosal human papillomavirus types.
Zubach V; Smart G; Ratnam S; Severini A
J Clin Microbiol; 2012 Feb; 50(2):460-4. PubMed ID: 22116162
[TBL] [Abstract][Full Text] [Related]
19. A human papilloma virus testing algorithm comprising a combination of the L1 broad-spectrum SPF10 PCR assay and a novel E6 high-risk multiplex type-specific genotyping PCR assay.
van Alewijk D; Kleter B; Vent M; Delroisse JM; de Koning M; van Doorn LJ; Quint W; Colau B
J Clin Microbiol; 2013 Apr; 51(4):1171-8. PubMed ID: 23363835
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of human papillomavirus infection among women from quilombo communities in northeastern Brazil.
Nascimento MDDSB; Vidal FCB; Silva MACND; Batista JE; Lacerda Barbosa MDC; Muniz Filho WE; Bezerra GFB; Castro Viana GM; Branco RCC; Brito LMO
BMC Womens Health; 2018 Jan; 18(1):1. PubMed ID: 29291721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
